
Pfizer Says Acquiring Medivation For $14 Billion
Umer Jamshaid Published August 22, 2016 | 10:11 PM

NEW YORK, (APP - UrduPoint / Pakistan Point News - 20th August, 2016) - Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday. Pfizer's offer for the San Francisco-based Medivation goes far beyond the company's market value of $11.1 billion. The boards of directors of both companies have unanimously approved the merger, the statement said. "The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer," said Ian Read, Pfizer chairman and chief executive officer. The transaction is a snub to the French pharmaceutical group Sanofi, which earlier offered $58 a share, which Medivation rejected in last month. Medivation turned down an uninvited offer worth about $10 billion from Sanofi as "not in the best interests" of its shareholders. The company's founder said Pfizer, by contrast, was the ideal marriage partner.
"We believe the combination with Pfizer is the right next step in our growth trajectory and is a testament to the passion and dedication by which the Medivation team has delivered on our mission to profoundly transform patients' lives through medically innovative therapies," said David Hung, founder, president and CEO of Medivation.
"This compelling transaction will deliver significant and immediate value to our stockholders and provides new opportunities for our employees as part of a larger company." By purchasing Medivation, Pfizer would add to its portfolio the drug Xtandi, a promising treatment against prostate cancer that analysts estimate will generate some $1.33 billion in annual sales by 2020.
It also produces the promising new talazoparib breast cancer drug, currently in a phase three study. The purchase of Medivation, if approved by regulators, would be Pfizer's biggest buy since it bought the medical device company Hospira last year for $17 billion.
Related Topics
Recent Stories

India cannot take unilateral decision on Indus Water Treaty: Federal Minister fo ..

Drug trafficker gets 9-year jail

Zimbabwe Air Chief calls on Air Marshal Zaheer Sidhu

CDA signs MoU to digitize financial system aims for cashless Islamabad

Welcome ceremony for newly admitted held at Bakhtawar Cadet Collage

Suspending Indus water treaty by India violation of Int’l laws: Minister for D ..

Obesity among youth causing early heart attacks in Pakistan: Dr Wajiha Javed

MoU signed for upgrading of Gadani shipbreaking yard

Allama Iqbal Literary Awards Ceremony organizes in Quetta

Pakistan to launch Sovereign Domestic Green Sukuk in May: Khurram Schehzad

APC opposes proposed KP Mines & Mineral Bill 2025

Delegation from ITUC calls on acting speaker
More Stories From World
-
Swiatek glad for high expectations ahead of Madrid title defence
9 minutes ago -
Football: Spanish La Liga results
19 minutes ago -
Prosecutors at Harvey Weinstein rape retrial say he made women 'small'
19 minutes ago -
I.Coast opposition calls marches against leader's eviction from electoral race
29 minutes ago -
Rohit, Boult star as Mumbai surge into IPL top four
49 minutes ago -
Football: Spanish La Liga table
49 minutes ago
-
Football: Italian Serie A table
1 hour ago -
Football: Italian Serie A results
2 hours ago -
French president announces economic deals with Madagascar
2 hours ago -
Boeing says China not accepting planes over US tariffs
2 hours ago -
Uzbekistan rises in global economic complexity rankings, outpacing regional peers
3 hours ago -
Pakistan Embassy in Beijing facilitates record Chinese participation at HEMS 2025 in Lahore
4 hours ago